A groundbreaking study by Northwestern Medicine has unveiled the intricate processes that enable ketamine to produce both immediate and enduring antidepressant...
VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”),...
NEW YORK, February 28, 2024–(BUSINESS WIRE)–Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (Cboe Canada:MMED), (the “Company” or “MindMed”), a...
SARASOTA, FL, Feb. 28, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical...
The growing market for vaporizers that offers portable, disposable and convenient delivery systems for DMT, psilocybin, 2C-B and other psychedelic substances. The...
TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — REVIVE THERAPEUTICS LTD. (CSE: RVV; OTCQB: RVVTF) (“Revive” or the “Company”) announces that it has...
Clearmind Medicine Inc., a name synonymous with innovation in the pharmaceutical sector, recently marked a significant milestone in its journey towards...
TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company...
Toronto, Ontario–(Newsfile Corp. – February 27, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or...
In the mid-20th century, psychedelic substances like LSD were explored for treating mood disorders and alcohol dependence. Their association with the 1960s...